Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.
25 Analysts have issued a Fresenius Medical Care forecast:
25 Analysts have issued a Fresenius Medical Care forecast:
| Jun '25 |
+/-
%
|
||
| Revenue | 19,518 19,518 |
1%
1%
|
|
| Gross Profit | 4,815 4,815 |
2%
2%
|
|
| EBITDA | 3,008 3,008 |
4%
4%
|
|
| EBIT (Operating Income) EBIT | 1,396 1,396 |
3%
3%
|
|
| Net Profit | 656 656 |
24%
24%
|
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Fresenius Medical Care AG & Co. KGaA engages in the provision of products and services for patients with chronic kidney failure. It also develop and manufacture a variety of health care products, which includes dialysis and non-dialysis products. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.
| Head office | Germany |
| CEO | Helen Giza |
| Employees | 111,513 |
| Founded | 1996 |
| Website | www.freseniusmedicalcare.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


